Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Majeed syndrome is a rare genetic multisystemic disorder characterized by the triad of chronic recurrent multifocal osteomyelitis, congenital dyserythropoietic anemia, and variable transient inflammatory dermatosis.
Features include always present findings: Elevated erythrocyte sedimentation rate, Joint swelling, Bone pain, and Delayed skeletal maturation and others; and very common findings: Hepatosplenomegaly. 18 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 5 | Joint swelling, Bone pain, Delayed skeletal maturation |
Blood and immune system | 3 | Decreased mean corpuscular volume, Anemia of inadequate production, Small red blood cells (microcytic anemia) |
Skin | 2 | Inflammatory abnormality of the skin, Skin rash |
Growth and development | 2 | Failure to thrive, Growth delay |
Muscles | 1 | Flexion contracture |
Prenatal/birth | 1 | Anemia of inadequate production |
Metabolism | 1 | Recurrent fever |
Hormones | 1 | Delayed puberty |
Digestive system | 1 | Hepatosplenomegaly |
Age of onset: childhood.
Individuals with LPIN2-related Majeed syndrome typically experience multisystem inflammatory symptoms, including chronic multifocal osteomyelitis, recurrent bone pain, recurrent fever, failure to thrive, dyserythropoietic anemia, and neutrophilic dermatosis. Because more than half of affected individuals have recurrent fever as one of the first manifestations, LPIN2-related Majeed syndrome should be considered in the spectrum of periodic fever syndromes in children . As more families are being described, individuals with milder features are now being recognized. To date, 32 individuals from 19 families have been identified with a pathogenic variant in LPIN2 [; ; Authors, personal observation]. The following description of the phenotypic features associated with this condition is based on these reports. Table 2. LPIN2-Related Majeed Syndrome: Frequency of Select Features
Feature | # of Persons w/Feature | Comment |
|---|---|---|
Chronic multifocal osteomyelitis | 32/32 (100%) | Recurrent episodes |
LPIN2 encodes lipin 2 (896 aa). Acts as a magnesium-dependent phosphatidate phosphatase enzyme which catalyzes the conversion of phosphatidic acid to diacylglycerol during triglyceride, phosphatidylcholine and phosphatidylethanolamine biosynthesis in the endoplasmic reticulum membrane. Highest expression in Liver (47.5 TPM) and Testis (37.8 TPM).
Majeed syndrome is caused by mutations in the LPIN2 gene on chromosome 18.
The LPIN2 protein participates in LPIN catalyzes conversion of phosphatidic acid to diacylglycerol, 1,2-diacyl-glycerol 3-phosphate + H2O = 1,2-diacyl-glycerol + orthophosphate, and DAG and Ca+2 bind to PKC and tether it to membrane pathways.
LPIN2 is classified as a druggable target (Enzyme category) with score 0.0.
No consensus clinical diagnostic criteria for LPIN2-related Majeed syndrome have been published.
LPIN2-related Majeed syndrome should be suspected in individuals with the following clinical, supportive laboratory, imaging, and family history findings.
Clinical findings
Recurrent bone pain near the joints, often of the long bones of the lower extremities
Joint swelling and subsequent joint contracture
Chronic recurrent multifocal osteomyelitis that is sterile
Neutrophilic dermatosis, which may present as painful erythematous plaques, pustules, or nodules with neutrophilic infiltrates
Note: This finding can be transient.
Failure to thrive
Recurrent fever
Hepatosplenomegaly
Gastrointestinal issues, including recurrent abdominal pain and/or recurrent diarrhea
Source: GeneReviews — "LPIN2-Related Majeed Syndrome"
Table 3.
Genes of Interest in the Differential Diagnosis of LPIN2-Related Majeed Syndrome
Gene | Disorder | MOI | Features of This Disorder
Overlapping w/LPIN2-related Majeed syndrome | Distinguishing from LPIN2-related Majeed syndrome
| Interleukin-1 receptor antagonist deficiency (OMIM 612852) | AR | Multifocal sterile osteomyelitis, ESR, CRP | Predominant skin pustulosis from early infancy
| Chronic infantile neurologic cutaneous articular syndrome (OMIM 607115) | AD | Recurrent fever, bone pain, skin rash | CNS involvement, chronic meningitis
| Pyogenic sterile arthritis, pyoderma gangrenosum, acne (OMIM 604416) | AD | Sterile arthritis, ESR, CRP | Acne, pyoderma gangrenosum
| TNF receptor-associated periodic fever syndrome | AD | Recurrent fever, ESR, CRP | Systemic ...
Source: GeneReviews — "LPIN2-Related Majeed Syndrome"
Genetic testing for LPIN2 is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for Majeed syndrome. The disease remains an area of unmet medical need.
No clinical practice guidelines for LPIN2-related Majeed syndrome have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with LPIN2-related Majeed syndrome, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with LPIN2-Related Majeed Syndrome
System/Concern | Evaluation | Comment |
|---|---|---|
Constitutional | Measurement of growth parameters | To assess for failure to thrive /or poor growth |
Musculoskeletal | Radiographs or MRI of any painful /or red, swollen limbs or joints | To assess for evidence of osteomyelitis Assessment for delayed motor milestones |
Gastrointestinal | Physical exam to evaluate for hepatosplenomegaly | If present, abdominal ultrasound to assess degree of organomegaly |
Hematologic | Measurement of CBC w/differential | To screen for microcytic anemia neutropenia |
Integument | Full skin exam | To assess for signs of dermatosis |
Source: GeneReviews — "LPIN2-Related Majeed Syndrome"
View trials for Majeed syndrome
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations in are recommended. Table 6. Recommended Surveillance for Individuals with LPIN2-Related Majeed Syndrome
System/Concern | Evaluation | Frequency |
|---|---|---|
Growth | Measurement of growth parameters | At each visit Musculoskeletal |
Immunologic | ESR CRP levels to monitor level of inflammation | At each visit |
Hematologic | CBC w/differential to assess for anemia neutropenia | Every 6 mos |
Integument | Full skin exam to assess for signs of dermatosis | At each visit CBC = complete blood count; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate |
Source: GeneReviews — "LPIN2-Related Majeed Syndrome"
Phenotype severity distribution: 8 always present features, 1 very common feature, 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Majeed syndrome.
9 publications have been identified in PubMed for Majeed syndrome. Research spans Review / Meta-Analysis (44%), Basic Science / Preclinical (22%), and Epidemiology / Natural History (22%).
Öner N (2026). [PMID: 41372712](https://pubmed.ncbi.nlm.nih.gov/41372712/). *Clin Rheumatol*. [Epidemiology / Natural History]
Drago E (2025). [PMID: 39255247](https://pubmed.ncbi.nlm.nih.gov/39255247/). *Rheumatology (Oxford)*. [Case Report / Case Series]
Welcome FS (2025). [PMID: 39948013](https://pubmed.ncbi.nlm.nih.gov/39948013/). *Adv Biol Regul*. [Review / Meta-Analysis]
Haşlak F (2025). [PMID: 39757386](https://pubmed.ncbi.nlm.nih.gov/39757386/). *Balkan Med J*. [Review / Meta-Analysis]
Vitkovska T (2025). [PMID: 41109341](https://pubmed.ncbi.nlm.nih.gov/41109341/). *J Biol Chem*. [Basic Science / Preclinical]
Vitkovska T (2025). [PMID: 40667007](https://pubmed.ncbi.nlm.nih.gov/40667007/). *bioRxiv*. [Basic Science / Preclinical]
Wang S (2025). [PMID: 41113563](https://pubmed.ncbi.nlm.nih.gov/41113563/). *Front Pediatr*. [Review / Meta-Analysis]
Kozu KT (2024). [PMID: 39175060](https://pubmed.ncbi.nlm.nih.gov/39175060/). *Adv Rheumatol*. [Review / Meta-Analysis]
Lv Q (2024). [PMID: 39360366](https://pubmed.ncbi.nlm.nih.gov/39360366/). *Clin Exp Rheumatol*. [Epidemiology / Natural History]
Data assembled from 8 of 12 sources · Last updated Sep 21, 2026, 4:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Majeed syndrome
Recurrent bone pain |
32/32 (100%) |
— |
Microcytic anemia | 29/30 (97%) | — |
Recurrent fever | 17/32 (53%) | — |
Growth restriction/ failure to thrive | 12/25 (48%) | — |
Hepatosplenomegaly | 10/22 (45%) | — |
Dermatosis | 4/28 (14%) | Chronic recurrent multifocal osteomyelitis (CRMO). Almost all affected individuals present with recurrent bone pain or clinical or radiologic evidence of CRMO. The symptoms usually start in the first two years of life. |
Source: GeneReviews — "LPIN2-Related Majeed Syndrome"
Genetic counseling |
By genetics professionals1 |
To inform affected persons their families re nature, MOI, implications of LPIN2-related Majeed syndrome to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with LPIN2-Related Majeed Syndrome Manifestation/Concern | Treatment1 | Considerations/Other Chronic multifocal or single-site sterile osteomyelitis |
Congenital dyserythropoiesis | Blood transfusion for severe anemia | This finding may improve w/anti-inflammatory treatment.; Splenectomy may be considered. |
Dermatosis | Anti-inflammatory medication (See above.) | Joint contractures/ |
Motor delay | Standard supportive therapies, incl PT /or OT | This finding may improve w/anti-inflammatory treatment. Anti-IL-1 = anti-interleukin-1; PT = physical therapy; OT = occupational therapy 1. Anti-inflammatory treatment decreases inflammation and reduces flare ups. |
Recommended Surveillance for Individuals with LPIN2-Related Majeed Syndrome System/Concern | Evaluation | Frequency |
Growth | Measurement of growth parameters | At each visit Musculoskeletal |
Immunologic | ESR CRP levels to monitor level of inflammation | At each visit |
Hematologic | CBC w/differential to assess for anemia neutropenia | Every 6 mos |
Integument | Full skin exam to assess for signs of dermatosis | At each visit CBC = complete blood count; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate For affected individuals managed with biologic or immunosuppressive medications, live-attenuated vaccines should be avoided, when possible. |